Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death

Marisa Granato(Sapienza University of Rome), Mara Cirone(Sapienza University of Rome)
Journal of Experimental & Clinical Cancer Research
November 28, 2017
Cited by 79


Related Papers